Peloton Wealth Strategists’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.43M Buy
307,350
+61,000
+25% +$1.29M 2.6% 9
2025
Q4
$5.21M Buy
246,350
+45,000
+22% +$954K 2.02% 15
2025
Q3
$4.27M Buy
201,350
+2,000
+1% +$42.1K 1.68% 21
2025
Q2
$4.19M Hold
199,350
1.68% 18
2025
Q1
$4.14M Buy
199,350
+29,350
+17% +$602K 1.73% 16
2024
Q4
$3.46M Buy
170,000
+22,300
+15% +$461K 1.4% 25
2024
Q3
$3.13M Buy
147,700
+27,700
+23% +$577K 1.25% 33
2024
Q2
$2.44M Buy
120,000
+11,500
+11% +$232K 1% 41
2024
Q1
$2.22M Buy
108,500
+6,000
+6% +$123K 0.9% 43
2023
Q4
$2.13M Buy
102,500
+67,500
+193% +$1.33M 0.92% 42
2023
Q3
$678K Buy
35,000
+18,800
+116% +$374K 0.31% 70
2023
Q2
$328K Buy
+16,200
New +$331K 0.15% 80

Other funds holding IBDW

Peloton Wealth Strategists's IBDW Position: Q1 2026 in Review

Peloton Wealth Strategists increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 25% in Q1 2026, buying an estimated $1.29M and bringing the position to 307,350 shares worth $6.43M. The position accounts for 2.6% of the portfolio, ranked #9.

Peloton Wealth Strategists first reported a position in IBDW in Q2 2023 and has held it in 12 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Peloton Wealth Strategists held 307,350 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $6.43M as of Q1 2026.
  • Peloton Wealth Strategists bought 61,000 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $1.29M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 2.6% of Peloton Wealth Strategists's portfolio in Q1 2026, its #9 holding.
  • Peloton Wealth Strategists first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q2 2023 and has held it in 12 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Peloton Wealth Strategists's 13F filing for Q1 2026, filed 14 May 2026.